BioNTech SE Deferred Tax Relating To Items Charged Or Credited Directly To Equity
BioNTech SE (BNTX) reported Deferred Tax Relating To Items Charged Or Credited Directly To Equity of EUR 18.10 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity · last filed 2026-03-10
| Period end | Deferred Tax Relating To Items Charged Or Credited Directly To Equity 12 month |
|---|---|
| 2025-12-31 | 18.10M EUR 20-F · filed 2026-03-10 |
| 2024-12-31 | -85.00M EUR 20-F · filed 2026-03-10 |
| 2023-12-31 | -169.10M EUR 20-F · filed 2024-03-20 |
| 2022-12-31 | 179.90M EUR 20-F · filed 2023-03-27 |